<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00261</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Reference substances.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> These may include, but need not  <!-- PJG 0012 frnewline --> be limited to, sodium azide, 2-nitrofluorene, 9-aminoacridine,  <!-- PJG 0012 frnewline --> 2-aminoanthracene, congo red, benzopurpurin 4B, trypan blue or  <!-- PJG 0012 frnewline --> direct blue 1.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (d) Test method._(1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Principle.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Motor vehicle combustion emissions from  <!-- PJG 0012 frnewline --> fuel or additive/base fuel mixtures are, first, filtered to trap  <!-- PJG 0012 frnewline --> particulate matter and, then, passed through a sorbent resin to  <!-- PJG 0012 frnewline --> trap semi-volatile gases. Bacteria are separately exposed to the  <!-- PJG 0012 frnewline --> extract from both the filtered particulates and the resin-trapped  <!-- PJG 0012 frnewline --> organics. Assays are conducted using both test mixtures with and  <!-- PJG 0012 frnewline --> without a metabolic activation system and exposed cells are  <!-- PJG 0012 frnewline --> plated onto minimal medium. After a suitable period of  <!-- PJG 0012 frnewline --> incubation, revertant colonies are counted in test cultures and  <!-- PJG 0012 frnewline --> compared to the number of spontaneous revertants in unexposed  <!-- PJG 0012 frnewline --> control cultures.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Description.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Several methods for performing the test  <!-- PJG 0012 frnewline --> have been described. The procedures described here are for the  <!-- PJG 0012 frnewline --> direct plate incorporation method and the azo-reduction method.  <!-- PJG 0012 frnewline --> Among those used are:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (i) Direct plate incorporation method;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Preincubation method;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) Azo-reduction method;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iv) Microsuspension method; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (v) Spiral assay.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Strain selection <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i) <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Designation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Five tester strains shall be used in the  <!-- PJG 0012 frnewline --> assay. At the present time, TA1535, TA1537, TA98, and TA100 are  <!-- PJG 0012 frnewline --> designated as tester strains. The fifth strain will be chosen  <!-- PJG 0012 frnewline --> from the pool of Salmonella strains commonly used to determine  <!-- PJG 0012 frnewline --> the degree to which nitrated organic compounds,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ,  <!-- PJG 0012 frnewline --> nitroarenes, contribute to the overall mutagenic activity of a  <!-- PJG 0012 frnewline --> test substance. TA98/1,8&hyph;DNP <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 6 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  or other suitable Rosenkranz  <!-- PJG 0012 frnewline --> nitro-reductase resistant strains will be considered acceptable.  <!-- PJG 0012 frnewline --> The choice of the particular strain is left to the discretion of  <!-- PJG 0012 frnewline --> the researcher. However, the researcher shall justify the use of  <!-- PJG 0012 frnewline --> the selected bacterial tester strains.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (ii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Preparation and storage of bacterial tester strains. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Recognized methods of stock culture preparation and storage shall  <!-- PJG 0012 frnewline --> be used. The requirement of histidine for growth shall be  <!-- PJG 0012 frnewline --> demonstrated for each strain. Other phenotypic characteristics  <!-- PJG 0012 frnewline --> shall be checked using such methods as crystal violet sensitivity  <!-- PJG 0012 frnewline --> and resistance to ampicillin. Spontaneous reversion frequency  <!-- PJG 0012 frnewline --> shall be in the range expected as reported in the literature and  <!-- PJG 0012 frnewline --> as established in the laboratory by historical control values.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Bacterial growth.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Fresh cultures of bacteria shall  <!-- PJG 0012 frnewline --> be grown up to the late exponential or early stationary phase of  <!-- PJG 0012 frnewline --> growth (approximately 108&hyph;109 cells per ml).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (4)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Exogenous metabolic activation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Bacteria shall be  <!-- PJG 0012 frnewline --> exposed to the test substance both in the presence and absence of  <!-- PJG 0012 frnewline --> an appropriate exogenous metabolic activation system. For the  <!-- PJG 0012 frnewline --> direct plate incorporation method, the most commonly used system  <!-- PJG 0012 frnewline --> is a cofactor-supplemented postmitochondrial fraction prepared  <!-- PJG 0012 frnewline --> from the livers of rodents treated with enzyme-inducing agents,  <!-- PJG 0012 frnewline --> such as Aroclor 1254. For the azo-reduction method, a cofactor-  <!-- PJG 0012 frnewline --> supplemented postmitochondrial fraction (S&hyph;9) prepared from the  <!-- PJG 0012 frnewline --> livers of untreated hamsters is preferred. For this method, the  <!-- PJG 0012 frnewline --> cofactor supplement shall contain flavin mononucleotide,  <!-- PJG 0012 frnewline --> exogenous glucose 6-phosphate dehydrogenase, NADH and excess of  <!-- PJG 0012 frnewline --> glucose-6-phosphate.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (5)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Control groups <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Concurrent controls.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Concurrent positive and negative (untreated) controls shall be included in each experiment. Positive controls shall ensure both strain responsiveness and  <!-- PJG 0012 frnewline --> efficacy of the metabolic activation system.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            